OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2017
(3)
2018
(2)
2015
(1)
2013
(1)
2009
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models.
Not available
S-EPMC6143222
|
biostudies-literature
Cite
Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality.
Not available
S-EPMC2633057
|
biostudies-literature
Cite
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade.
Not available
S-EPMC5593544
|
biostudies-literature
Cite
Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancer.
Not available
S-EPMC3674958
|
biostudies-literature
Cite
The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapy.
Not available
S-EPMC5762293
|
biostudies-literature
Cite
Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms.
Not available
S-EPMC6168336
|
biostudies-literature
Cite
Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Not available
S-EPMC5025278
|
biostudies-literature
Cite
Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model.
Not available
S-EPMC4323738
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets